Evidence map›Paper›PMID 33600842›Full record

ReviewNeuropharmacology2021

Sex differences in progestogen- and androgen-derived neurosteroids in vulnerability to alcohol and stress-related disorders.

MacKenzie R Peltier, Terril L Verplaetse, Yann S Mineur, Ralitza Gueorguieva, Ismene Petrakis, Kelly P Cosgrove, Marina R Picciotto, Sherry A McKee

Open access · greenAbstract readReview
In one paragraph

Review in Neuropharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Major depressive disorder-alcohol use disorder comorbidity: diagnosis, mechanisms and treatment.European archives of psychiatry and clinical neuroscience · 2026
    Review
  4. Observational
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

MacKenzie R PeltierYale School of Medicine, New Haven, CT, 06519, USA; VA Connecticut Healthcare System, West Haven, CT, 06516, USA. Electronic address: mackenzie.peltier@yale.edu.
Terril L VerplaetseYale School of Medicine, New Haven, CT, 06519, USA.
Yann S MineurYale School of Medicine, New Haven, CT, 06519, USA.
Ralitza GueorguievaYale School of Medicine, New Haven, CT, 06519, USA; Yale School of Public Health, New Haven, CT, 06519, USA.
Ismene PetrakisYale School of Medicine, New Haven, CT, 06519, USA; VA Connecticut Healthcare System, West Haven, CT, 06516, USA.
Kelly P CosgroveYale School of Medicine, New Haven, CT, 06519, USA.
Marina R PicciottoYale School of Medicine, New Haven, CT, 06519, USA.
Sherry A McKeeYale School of Medicine, New Haven, CT, 06519, USA.
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale-SCORE Resource Support CoreU54AA027989 · NIAAA · YALE UNIVERSITY · PI Sherry Ann McKee · 2020 to 2026
$13.0M
Yale SCOR on Gender-Sensitive Treatment for Tobacco DependenceP50DA033945 · NIDA · YALE UNIVERSITY · PI MCKEE, SHERRY ANN · 2012 to 2017
$6.5M
Imaging Microglial Activation in PTSD with PETR01MH110674 · NIMH · YALE UNIVERSITY · PI COSGROVE, KELLY P., PIETRZAK, ROBERT H · 2017 to 2020
$3.1M
Sex-Appropriate Treatment Development for Alcohol Use DisordersP01AA027473 · NIAAA · YALE UNIVERSITY · PI COSGROVE, KELLY P. · 2018 to 2019
$1.0M
Behavioral and Neurochemical Mechanisms Underlying Stress-Precipitated DrinkingK01AA025670 · NIAAA · YALE UNIVERSITY · PI VERPLAETSE, TERRIL L · 2018 to 2023
$882k
Does endotoxin administration increase alcohol consumption in individuals with AUD?R03AA028361 · NIAAA · YALE UNIVERSITY · PI VERPLAETSE, TERRIL L · 2021 to 2022
$168k
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS K01 AA025670NIAAA NIH HHS P01 AA027473NIAAA NIH HHS R03 AA028361NIAAA NIH HHS U54 AA027989NIDA NIH HHS P50 DA033945NIMH NIH HHS R01 MH110674
6 · The paper itself

Abstract

Stress and trauma exposure disturbs stress regulation systems and thus increases the vulnerability for stress-related disorders which are characterized by negative affect, including major depressive disorder, anxiety disorders and posttraumatic stress disorder. Similarly, stress and trauma exposure results in increased vulnerability to problematic alcohol use and alcohol use disorder, especially among women, who are more likely to drink to cope with negative affect than their male counterparts. Given these associations, the relationship between stress-related disorders and alcohol use is generally stronger among women leading to complex comorbidities across these disorders and alcohol misuse. This review highlights the therapeutic potential for progestogen- and androgen-derived neurosteroids, which affect both stress- and alcohol-related disorders, to target the overlapping symptoms related to negative affect. This article is part of the special issue on 'Vulnerabilities to Substance Abuse.'

Indexed as

AffectAlcohol-Related DisordersAndrogensDehydroepiandrosteroneEstradiolFemaleHumansMaleNeurosteroidsPregnanoloneProgesteroneProgestinsSex FactorsStress Disorders, TraumaticTestosteroneAndrogensDehydroepiandrosteroneEstradiolNeurosteroidsPregnanoloneProgesteroneProgestinsTestosteroneAlcoholAndrogen-derivedNeurosteroidsProgestogen-derivedSex differencesStress-related disorders

Identifiers

PMID33600842
PMCPMC7992136
OpenAlexW3130305012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.